Search

Stuart J Perper

from Uxbridge, MA
Age ~61
Get Report
Also known as:
Stuart James Perper, Stuart J Pepper, Staurt Perper
Phone and address:
17 Stony Woods Dr, Uxbridge, MA 01569
(508) 779-0750
Related to:
Kevin R Concannon, 68Hilda Rodgers, 55Maria Y Ruiz, 73Catherine RogersRodney Mckinney, 52Mark Rogers
Connected to:
Gloria A Perperas, 69Serafima Perper, 57Angela M Perpetua, 38Cristiane D Perpetuo, 47Gary O Perpetua, 101Gregory S Perpetua, 52George A Perpich, 70James M Perpich, 67John P Perpich, 38Kristopher J Perpich, 46

Stuart Perper Phones & Addresses

  • 17 Stony Woods Dr, Uxbridge, MA 01569 (508) 779-0750
  • Killingly, CT
  • 10 Partridge Trl, Bellingham, MA 02019 (508) 883-3050
  • 26 Stone St, Bellingham, MA 02019 (508) 966-3254
  • Marlborough, MA
  • Framingham, MA

Work

Company: Renamed biologics Position: Senior development associate

Education

School / High School: Cornell University 1985 to 1987

Skills

Inside Sales • Computer Science • Sales

Industries

Biotechnology

Resumes

Resumes

Stuart Perper Photo 1

Senior Development Associate

View page
Location:
17 Stony Woods Dr, Uxbridge, MA 01569
Industry:
Biotechnology
Work:
Renamed Biologics
Senior Development Associate
Education:
Cornell University 1985 - 1987
Skills:
Inside Sales
Computer Science
Sales

Publications

Us Patents

Methods Of Treatment Using Selective Bcl-2 Inhibitors

View page
US Patent:
20120129853, May 24, 2012
Filed:
Nov 22, 2011
Appl. No.:
13/301898
Inventors:
Steven Elmore - Northbrook IL, US
Andrew Souers - Evanston IL, US
Li Chun Wang - North Grafton MA, US
Tariq Ghayur - Holliston MA, US
Stuart J. Perper - Bellingham MA, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/5377
A61P 37/06
A61P 13/12
A61K 31/496
US Classification:
5142345, 51425304, 5142358, 51425409, 51425309, 51425211
Abstract:
This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-x.

Methods Of Treatment Using Selective Bcl-2 Inhibitors

View page
US Patent:
20200222413, Jul 16, 2020
Filed:
May 17, 2019
Appl. No.:
16/415515
Inventors:
- North Chicago IL, US
Andrew Souers - Evanston IL, US
Lichun Wang - North Grafton MA, US
Tariq Ghayur - Holliston MA, US
Stuart J. Perper - Bellingham MA, US
International Classification:
A61K 31/5377
A61K 31/496
Abstract:
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-X.

Methods Of Treatment Using Selective Bcl-2 Inhibitors

View page
US Patent:
20180369250, Dec 27, 2018
Filed:
Dec 12, 2017
Appl. No.:
15/838605
Inventors:
- North Chicago IL, US
Andrew Souers - Evanston IL, US
Lichun Wang - North Grafton MA, US
Tariq Ghayur - Holliston MA, US
Stuart J. Perper - Bellingham MA, US
International Classification:
A61K 31/5377
A61K 31/496
Abstract:
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-X.

Methods Of Treatment Using Selective Bcl-2 Inhibitors

View page
US Patent:
20170232000, Aug 17, 2017
Filed:
Apr 22, 2016
Appl. No.:
15/136582
Inventors:
- North Chicago IL, US
Andrew Souers - Evanston IL, US
Lichun Wang - North Grafton MA, US
Tariq Ghayur - Holliston MA, US
Stuart J. Perper - Bellingham MA, US
International Classification:
A61K 31/5377
A61K 31/496
Abstract:
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-X

Methods Of Treatment Using Selective Bcl-2 Inhibitors

View page
US Patent:
20150150870, Jun 4, 2015
Filed:
Nov 6, 2014
Appl. No.:
14/535070
Inventors:
- North Chicago IL, US
Andrew Souers - Evanston IL, US
Lichun Wang - North Grafton MA, US
Tariq Ghayur - Holliston MA, US
Stuart J. Perper - Bellingham MA, US
International Classification:
A61K 31/496
A61K 31/5377
Abstract:
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-x.
Control profile
Stuart J Perper from Uxbridge, MA, age ~61 Get Report